相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel germline mutation in Peroxisome Proliferator-Activated Receptor γ gene associated with large intestine polyp formation and dyslipidemia
D. Capaccio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Joost H. A. Martens et al.
CANCER CELL (2010)
Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis
Makoto Koyama et al.
CLINICAL CANCER RESEARCH (2010)
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Jelena Mann et al.
GASTROENTEROLOGY (2010)
Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
Massimo Pancione et al.
HUMAN PATHOLOGY (2010)
Expression of the peroxisome proliferator activated receptor γ gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes
Katsunori Fujiki et al.
BMC BIOLOGY (2009)
Identification of Novel Trophoblast Invasion-Related Genes: Heme Oxygenase-1 Controls Motility via Peroxisome Proliferator-Activated Receptor γ
Martin Bilban et al.
ENDOCRINOLOGY (2009)
PPARG: A New Independent Marker for Colorectal Cancer Survival
Geoffrey Girnun
GASTROENTEROLOGY (2009)
Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis
Shuji Ogino et al.
GASTROENTEROLOGY (2009)
Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome
Massimo Pancione et al.
HUMAN PATHOLOGY (2009)
Maternal Pregestational BMI Is Associated With Methylation of the PPARGC1A Promoter in Newborns
Carolina Gemma et al.
OBESITY (2009)
The MBD protein family-Reading an epigenetic mark?
Archana Dhasarathy et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
MAPK kinases as nucleo-cytoplasmic shuttles for PPARγ
Elke Burgermeister et al.
CELL CYCLE (2007)
Synergy between PPARγ ligands and platinum-based drugs in cancer
Geoffrey D. Girnun et al.
CANCER CELL (2007)
Peroxisome proliferator-activated receptor γ is a Zac target gene mediating Zac antiproliferation
Thomas Barz et al.
CANCER RESEARCH (2006)
From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
JN Feige et al.
PROGRESS IN LIPID RESEARCH (2006)
A novel peroxisome proliferator-activated receptor γ isoform with dominant negative activity generated by alternative splicing
L Sabatino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Peroxisome proliferator-activated receptor-γ calls for activation in moderation:: Lessons from genetics and pharmacology
C Knouff et al.
ENDOCRINE REVIEWS (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
Nuclear receptors and the control of metabolism
GA Francis et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
H Suzuki et al.
NATURE GENETICS (2002)
分享论文
